Lifecore Biomedical, Inc. LFCR Cash Flow Statement
| Q4 '26 | Q2 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$14.98M-1,206% | -$9.99M-52.0% | -$1.15M— | -$14.77M-194% | -$6.57M-146% | ||
| $2.31M+20.7% | $1.98M-3.1% | $1.91M-5.0% | $2.08M+3.5% | $2.04M+15.7% | ||
| $1.7M-6.4% | $2.39M-29.1% | $1.82M+13.6% | $2.55M+70.9% | $3.37M+114% | ||
| $0+100% | —— | -$91K— | -$7.64M— | —— | ||
| -$930K+59.6% | -$1.97M+18.9% | -$2.3M— | -$4.62M-160% | -$2.43M— | ||
| $1.43M— | $2.26M— | —— | -$3.51M-885% | —— | ||
| -$3.65M-4.4% | -$3.56M-182% | -$3.5M-160% | $225K+107% | -$1.26M-9.7% | ||
| -$209K+87.1% | $90K-90.3% | -$1.61M-85.5% | $97K— | $925K+121% | ||
| $46K— | -$255K— | —— | -$333K+80.5% | —— | ||
| -$6.77M-508% | $4.58M+32.8% | $1.66M+201% | $3.23M— | $3.45M— | ||
| $4.7M— | $1.76M+129% | —— | $1.2M+185% | -$6.14M-577% | ||
| $1.12M-46.7% | $1.74M-28.8% | $2.1M-22.7% | $5.46M-14.3% | $2.44M-42.7% | ||
| $0— | —— | —— | $7M— | —— | ||
| -$1.12M+46.7% | -$1.74M+28.8% | -$2.1M+22.7% | $1.54M+124% | -$2.44M+42.7% | ||
| $36.4M— | $12.1M— | —— | $33.89M+17,461% | —— | ||
| $0-100% | $1.16M+200% | $163K+208% | $134K+219% | $385K+3,108% | ||
| -$256K— | -$1.39M-111% | $0— | -$6.78M-189% | $12.52M— | ||
| $3.33M— | -$1.36M-135% | —— | -$4.04M-2,630% | $3.94M+173% | ||
| $2.31M— | —— | —— | $2.08M— | —— | ||
| $0— | —— | —— | -$7.64M-169,633% | —— | ||
| —— | —— | $660.5K— | $660.5K— | $660.5K— | ||
| -$3.65M-4.4% | -$3.56M-50.1% | -$3.5M-160% | $225K— | -$2.37M— | ||
| $206K-75.2% | -$4.64M-395% | $829K+226% | $452K— | $1.57M— | ||
| -$209K+87.1% | $90K-90.3% | -$1.61M-85.5% | $97K— | $925K+121% | ||
| $46K— | -$255K— | —— | -$333K+80.5% | —— | ||
| $7.08M— | $6.11M— | —— | $5.21M+60.0% | —— | ||
| -$3.16M— | -$375K-131% | —— | -$600K-103% | $1.2M-94.2% | ||
| $0— | —— | —— | $7M— | —— | ||
| -$256K— | —— | —— | -$649K— | —— | ||
| $36.4M— | $12.1M— | —— | $33.89M-7.6% | —— | ||
| $36.4M— | $12.1M— | —— | $27.89M-25.4% | —— | ||
| $3.58M— | $25K+100% | —— | -$4.26M+45.3% | -$8.58M-189% | ||
| $3.58M— | $25K+100% | —— | -$4.26M+45.3% | -$8.58M-189% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Lifecore Biomedical, Inc. generate?
- Lifecore Biomedical, Inc. (LFCR) generated $1.5M in operating cash flow over the trailing twelve months.
- What is Lifecore Biomedical, Inc.'s free cash flow?
- After $10.4M of capital expenditures, Lifecore Biomedical, Inc.'s free cash flow was -$9.2M over the trailing twelve months, up 67.2% year over year.
- Where does Lifecore Biomedical, Inc.'s cash flow data come from?
- Every line is extracted from Lifecore Biomedical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
